Altered Plasma Mitochondrial Metabolites in Persistently Symptomatic Individuals after a GBCA-Assisted MRI (2022).

Written By Kate

Download: https://www.mdpi.com/2305-6304/10/2/56

Journal: Toxics

Authors: DeAunne Denmark1, Ilene Ruhoy 2, Bryan Wittmann 3, Haleh Ashki 4 and Lorrin M. Koran 5,*

1Department of Behavioral Neuroscience, Oregon Health & Science University, 3710 SW US Veterans Hospital Road, Mail Code R&D40, Portland, OR 97239, USA

2 Mount Sinai South Nassau Chiari-EDS Center, 1420 Broadway, Hewlett, NY 11557, USA

3 Owlstone Medical, 600 Park Offices Drive, Suite 140, Research Triangle Park, NC 27709, USA

4 Prime Genomics, Inc., 319 Bernardo Avenue, Mountain View, CA 94041, USA

5 Department of Psychiatry and Behavioral Sciences, OCD Clinic, Stanford University Medical Center, 401 Quarry Road, Stanford, CA 94305, USA

*Author to whom correspondence should be addressed.

Kate
Previous

Symptoms Associated with Gadolinium Exposure (SAGE): A Suggested Term (2022).
Next

Dynamic Serial Cytokine Measurements During Intravenous Ca-DTPA Chelation in Gadolinium Deposition Disease and Gadolinium Storage Condition: A Pilot Study (2022).